Peyer James's Form 4 filing
Faeth Therapeutics, Inc. (FTH) · filed Mar 2, 2022
- Accession no.
- 0001567619-22-006006
- Filed
- Mar 2, 2022
- Trade date
- Mar 2, 2022
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $3.85K. It was filed on the trade date.
This filing was later replaced by the amendment 0001567619-22-012647 (Jun 10, 2022). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Peyer JamesCIK 0001843594 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2022 | Common Stock | PPurchaseAcquired | +1,203 | $3.20 | +$3,849.6 | 5,231,989 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.